Brief: Hofseth Biocare Q4 Adjusted EBITDA Loss NOK 26.1 Mln
Feb 14 (Reuters) - Hofseth Biocare ASA HBC.OL :
* Q4 ADJUSTED EBITDA LOSS NOK 26.1 MILLION VERSUS LOSS NOK
39.8
MILLION YEAR AGO
* Q4 GROSS OPERATING REVENUE NOK 64.9M (47.4M)
Source text: ID:nGNEtMghB
Further company coverage: HBC.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Hofseth Biocare ASA
See all newsBrief: HBC Publishes Clinical Trial, Calls It Paradigm-Changing
Brief: Hofseth Biocare Says Demand Outlook For 2026 Is Improving Rapidly
Norway's Hofseth Biocare Q4 revenue rises on Human Nutrition demand
Brief: Hofseth BioCare To Cancel Subsequent Offering
Brief: Hofseth Biocare Announces Results Of Subsequent Offering